Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Beck

Showing results (701-710 of 719) with videos related to

Pageof 72
Sort By:
NPJ Genomic Medicine|November 25, 2021
Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
NPJ Genomic Medicine|November 9, 2021
Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Journal of the American Society of Nephrology : JASN|October 5, 2021
mTOR-Activating Mutations in <i>RRAGD</i> Are Causative for Kidney Tubulopathy and CardiomyopathyKarl P Schlingmann, François Jouret, Kuang Shen, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
Proceedings. Biological Sciences|July 22, 2025
Perceived and observed biases within scientific communities: a case study in movement ecologyAllison K Shaw, Leila Fouda, Stefano Mezzini, et al.
American Journal of Medical Genetics. Part A|February 1, 2021
Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesKevin E Glinton, Anna C E Hurst, Kevin M Bowling, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Kidney International|August 5, 2020
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypesMartina Živná, Kendrah Kidd, Mohamad Zaidan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 72

Showing results (701-710 of 719) with videos related to

Sort By:
Pageof 72
NPJ Genomic Medicine|November 25, 2021
Author Correction: Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Blood|July 6, 2022
Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesisMarcela A Ferrada, Sinisa Savic, Daniela Ospina Cardona, et al.
NPJ Genomic Medicine|November 9, 2021
Deficiency of TET3 leads to a genome-wide DNA hypermethylation episignature in human whole bloodMichael A Levy, David B Beck, Kay Metcalfe, et al.
Journal of the American Society of Nephrology : JASN|October 5, 2021
mTOR-Activating Mutations in <i>RRAGD</i> Are Causative for Kidney Tubulopathy and CardiomyopathyKarl P Schlingmann, François Jouret, Kuang Shen, et al.
Blood|February 2, 2024
Venous and arterial thrombosis in patients with VEXAS syndromeYael Kusne, Atefeh Ghorbanzadeh, Alina Dulau-Florea, et al.
Proceedings. Biological Sciences|July 22, 2025
Perceived and observed biases within scientific communities: a case study in movement ecologyAllison K Shaw, Leila Fouda, Stefano Mezzini, et al.
American Journal of Medical Genetics. Part A|February 1, 2021
Phenotypic expansion of the BPTF-related neurodevelopmental disorder with dysmorphic facies and distal limb anomaliesKevin E Glinton, Anna C E Hurst, Kevin M Bowling, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Kidney International|August 5, 2020
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypesMartina Živná, Kendrah Kidd, Mohamad Zaidan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Pageof 72